A new stainless steel spiral Schlemm's canal expander in surgical treatment open-angle glaucoma

PURPOSE: To evaluate the safety and effectiveness of Schlemm's canal (SC) dilation with stainless steel spiral Schlemm's canal expander (SCE) in decreasing intraocular pressure (IOP) in patients with open angle glaucoma (OAG). MATERIAL AND METHODS: Eighteen consecutive patients (18 eyes) with OAG, who's IOP was insufficiently controlled by their current ocular hypotensive medications were operated upon. A 4-5 mm long SCE made from 0.05 mm thick medical grade stainless steel wire was implanted into the SC lumen ab externo. In 6 cases with coexisting pathology a combined two site procedure - phacoemulsification with implantation of an intraocular lens (IOL) and SCE implantation was performed. Primary outcome measure was IOP change, secondary - number of glaucoma medications pre-and postoperatively and complications. A paired t-test was used for IOP and medication analysis. Decrease in IOP >25% or IOP 18 mm Hg or less without medication was considered a complete success, with medication - partial success. Failure was considered if the patient needed subsequent filtering surgery. Results were significant with p<0.05. Mean postoperative follow-up was 9.5±2.7 months. RESULTS: Mean preoperative IOP was 25.8±6.2 mm Hg (95% CI 22.7-28.9), mean number of medications - 2.4±0.8 (95% CI 2.2-2.6). At each follow-up a decrease in mean IOP was observed, resulting in 11.9±3.0 mm Hg (95% CI 11.513.1) at 6 months (p=0.000000008) and 12.3±2.5 mm Hg (n=10; 95% CI 11.2-12.6) at 12 months (p=0.00000001). This represents a reduction in IOP from baseline of 51.7±19.0% (95% CI 47.2-56.2) at 6 months and 49.8±15.3% (95% CI 45.0-54.6) at 12 months. Mean number of medications use decreased to 0.6±1.1 (95% CI 0.3-0.9; p=0.0000002) and 0.9±1.3 (95% CI 0.5-1.3; p=0.004) at 6 and 12 months respectively. Complete and partial success were observed in 13 and 5 cases at 6 months and 6 and 4 cases at 12 months (n=10). Intraoperatively, microperforation of trabecular meshwork (TM) in areas other than exposed part of SC occurred in 3 out of 18 cases. Postoperatively, not a single case of inflammation at insertion site, of hypotony, or shallow chamber was observed. Gonioscopically the device was in SC in all, except 2 cases, where one end of the device was lying in anterior chamber without contact with intraocular structures. Some blood was observed in SC at the device site in 3 cases, which cleared spontaneously after 3-4 days. There was 1 case with raised IOP after operation, which required Nd-YAG laser trabeculopuncture and one glaucoma medication. There were no failure cases. CONCLUSION: Six months and one year results of SCE insertion in surgical management of OAG show significant reduction in IOP from the baseline and in hypotensive medications use.

Schlemm's canal surgery, Schlemm's canal expander, glaucoma surgery, open angle glaucoma, minimally invasive glaucoma surgery, хирургия шлеммова канала, экспандер шлеммова канала, хирургия глаукомы, открыто-угольная глаукома, миниинвазивная хирургия глаукомы

1. Gedde S.J., Herndon L.W., Brandt J.D., et al. Surgical complications in the tube versus trabeculectomy study during the first year of follow-up. Am J Ophthalmol 2007; 143:23-31.

2. Scott I.U., Greenfield D.S., Schiffman J., et al. Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol 1998; 116:286-91.

3. Edmunds B., Thompson J.R., Salmon J.F., et al. The National Survey of Trabeculectomy. III. Early and late complications. Eye 2002; 16:297-303.

4. Jampel H.D., Musch D.C., Gillespie B.W., et al. Perioperative complications of trabeculectomy in the CIGTS. Am J Ophthal-mol 2005; 140:16-22.

5. Fontana H., Nouri-Mahdavi K., Lumba J., et al. Trabeculecto-my with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. Ophthalmology 2006; 113:930-6.

6. Shingleton B.J., Pasternack J.J., Hung J.W., et al. Three and five year changes in intraocular pressures after clear cor-neal phacoemulsification in open angle glaucoma patients, glaucoma suspects, and normal patients. J Glaucoma 2006; 15(6):494-498.

7. Augustinus C.J., Zeyen T. The effect of phacoemulsification and combined phaco/glaucoma procedures on the intraocular pressure in open angle glaucoma. A review of literature. Bull Soc Belge Ophthalmol 2012; 320: 51-66.

8. Stegmann R., Pienaar A., Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg 1999; 25:316-322.

9. Carassa R.G., Bettin P., Fiori M., et al. Viscocanalostomy versus trabeculectomy in white adults affected by open-angle glaucoma. A 2-year randomized, controlled trial. Ophthalmology 2003; 110:882-887.

10. Kobayashi H., Kobayashi K., Okinami S. A comparison of the intraocular pressure-lowering effect and safety of viscoca-nalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2003; 241:359-366.

11. Николашин С.И., Мачехин В.А. Непроникающая глубокая склерэктомия с дренированием Шлеммова канала в лечении первичной открытоугольной глаукомы. Офтальмохирургия 2002; 1:17-20.

12. Федоров С.Н., Козлов В.И., Тимошкина Н.Т. и др. Непроникающая глубокая склерэктомия при открытоугольной глаукоме. Офтальмохирургия 1989; 3-4:52-55.

13. Shingleton B., Tetz M., Korber N. Circumferential viscodilation and tensioning of Schlemm canal (canaloplasty) with temporal clear corneal phacoemulsification cataract surgery for open-angle glaucoma and visually significant cataract: one-year results. J Cataract Refract Surg 2008; 34:433-440.

14. Lewis R.A., von Wolff K., Tetz M., et al. Canaloplasty: circumferential viscodilation and tensioning of Schlemm canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: two-year interim clinical study analysis. J Cataract Refract Surg 2009; 35:814-824.

15. Lewis R.A., von Wolff K., Tetz M., et al. Canaloplasty: Three-year results of circumferential viscodilation and tensioning of Schlemm's canal using a microcatheter to treat open-angle glaucoma. J Cataract Refract Surg 2011; 37(4):682-690.

16. Ayyala R.S., Chaudhry A.L., Okogbaa C.B., et al. Comparison of surgical outcomes between canaloplasty and trabeculecto-my at 12 months' follow-up. Ophthalmology 2011; 118(12): 2427-2433.

17. Grieshaber M.C., Pienaar A., Olivier J., et al. Canaloplasty for primary open-angle glaucoma: long-term outcome. Br J Oph-thalmol 2010; 94(11):1478-1482.

18. Краснов М.М. Микрохирургия глауком. М.; 1980. 235-236.

19. Poulsen E.J., Allingham R.R. Characteristics and risk factors of infections after glaucoma filtering surgery. J Glaucoma 2000; 9:438-443.

20. DeBry P.W., Perkins T.W., Heatley G., et al. Incidence of late onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 2002; 120:297-300.

21. Vandewalle E., Zeyen T., Stalmans I. The iStent trabecular micro-bypass stent: a case series. Bull Soc Belge Ophtalmol 2009; 311:23-29.

22. Belovay G.W., Naqi A., Chan B.J., et al. Using multiple trabecu-lar micro-bypass stents in cataract patients to treat open-angle glaucoma. J Cataract Refract Surg 2012; 38(11):1911-1917.

23. Saheb H., Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 2012; 23(2):96-104.

24. Arriola-Villalobos P., Martfnez-de-la-Casa J.M., Diaz-Valle D., et al. Mid-term evaluation of the new Glaukos iStent with phacoemulsification in coexistent open-angle glaucoma or ocular hypertension and cataract. Br J Ophthalmol 2013; 97:1250-1255.

25. Grant W.M. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol 1963; 69:738-801.

26. Johnson D.H., Johnson M. How does nonpenetrating glaucoma surgery work? Aqueous outflow pathway morphology. Invest Ophthalmol Vis Sci 1999; 40:1676-1680.

27. Tetz M. A novel intracanalicular implant for IOP reduction in patients with POAG: surgical and initial coutcomes from the HYDRUS I study. ESCRS 2011. Free paper. Vienna.

28. Grieshaber M.C., Pienaar A., Olivier J., et al. Channelography: imaging of the aqueous outflow pathway with flexible micro-catheter and fluorescein in canaloplasty. Klin Monatsbl Augen-heilkd 2009; 226:245-248.

29. Grieshaber M.C., Pienaar A., Olivier J., et al. Clinical evaluation of the aqueous outflow system in primary open angle glaucoma for canaloplasty. Invest Ophthalmol Vis Sci 2010b; 51:1498-1504.

30. Grieshaber M.C., Pienaar A., Olivier J., et al. Comparing two tensioning suture sizes for 360o viscocanalostomy (canaloplasty): a randomized controlled trial. Eye 2010c; 24:1220-1226.

31. Grieshaber M.C., Fraenkl S., Schoetzau A., et al. Circumferential viscocanalostomy and suture canal distension (canaloplas-ty) for Whites with open-angle glaucoma. J Glaucoma 2011; 20:298-302.

32. Fujita K., Kitagawa K., Ueta Y., et al. Short-term results of canaloplasty surgery for primary open-angle glaucoma in Japanese patients. Case Rep Ophthalmol 2011; 2:65-68.

33. Johnstone M., Curtis K., Passin D., et al. New imaging techniques to study transparent tobules (TT) spanning Schlemm's canal structures subject to disruption by SC surgery. AGS 21st annual meeting 2011, poster abstracts, poster N 32.